Exagen (XGN) Stock Price Target 2026

The average analyst price target for Exagen is $9.78, 12.7% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $7 to $12. The latest change came on Oct 19, 2026, when Canaccord Genuity raised its price target on Exagen from $9 to $11 and kept a Buy rating.

The Average Analyst Price Target for Exagen is $9.78.

Price Target Range — 9 Quarters

Analyst Consensus — 8 Analysts

8Buy

Consensus RatingBuy# Analysts8Avg. Consensus PT$9.78Upside to Avg. PT+12.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Exagen Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 19, 2026	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$9→$11
Oct 13, 2026	TD Cowen	Dan Bergstrom	PT Raise	Buy	$10→$11
Aug 5, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$8→$10
Aug 5, 2026	B. Riley Securities	Anderson Schock	PT Raise	Buy	$8→$12
Aug 5, 2026	BTIG	Mark Massaro	PT Raise	Buy	$8→$9
Jun 25, 2026	Roth Capital	Max Masucci	Initiate	Buy	$8
May 12, 2026	BTIG	Mark Massaro	PT Cut	Buy	$9→$8
Apr 20, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$10→$8
Mar 11, 2026	Canaccord Genuity	Kyle Mikson	PT Cut	Buy	$15→$10
Mar 11, 2026	Craig-Hallum	John Wilkin	PT Cut	Buy	$12→$10
Mar 11, 2026	Keybanc	Paul Knight	PT Cut	Overweight	$15→$10
Mar 10, 2026	BTIG	Mark Massaro	PT Cut	Buy	$10→$9
Feb 24, 2026	TD Cowen	Dan Brennan	PT Cut	Buy	$13→$10
Feb 17, 2026	BTIG	Mark Massaro	PT Cut	Buy	$15→$10
Jan 30, 2026	B. Riley Securities	Anderson Schock	PT Cut	Buy	$18→$8
Nov 10, 2025	BTIG	Mark Massaro	PT Raise	Buy	$13→$15
Nov 5, 2025	B. Riley Securities	Anderson Schock	PT Raise	Buy	$15→$18
Oct 27, 2025	Canaccord Genuity	Kyle Mikson	PT Raise	Buy	$11→$15
Oct 22, 2025	BTIG	Mark Massaro	PT Raise	Buy	$11→$13
Oct 14, 2025	Keybanc	Paul Knight	PT Raise	Overweight	$12→$15